HDAC3 and rheumatoid arthritis: Interestingly and unlike pan-HDACi, HDAC3 inhibitor MI192 was able to inhibit the inflammatory response in peripheral blood mononuclear cells (PBMCs) of RA patients but not in PBMCs of healthy control [68].